Newsmakers

Healthcare

CytoDyn (OTC: CYDY) So. California Patients Treated with Leronlimab for COVID-19 under Emergency IND: 4 Patients with Moderate Indications Removed from Oxygen; 3 Patients Discharged from Hospital; 1 Patient Scheduled for Discharge Today; 1 Patient with Severe Indications Discharged, for Total of 5 Patients Discharged

April 13, 2020 admin Comments Off on CytoDyn (OTC: CYDY) So. California Patients Treated with Leronlimab for COVID-19 under Emergency IND: 4 Patients with Moderate Indications Removed from Oxygen; 3 Patients Discharged from Hospital; 1 Patient Scheduled for Discharge Today; 1 Patient with Severe Indications Discharged, for Total of 5 Patients Discharged

VANCOUVER, Washington, Apr 13, 2020  — More than 25 EINDs approved by FDA for leronlimab use in COVID-19 patients Phase 2 trial – As of last week, 12 patients enrolled from 2 sites; 3 more […]

Newsmakers

Floyd Mayweather, fuboTV (OTC: FBNK) Partner in Ground-Breaking Digital Likeness Joint Venture

April 12, 2020 admin Comments Off on Floyd Mayweather, fuboTV (OTC: FBNK) Partner in Ground-Breaking Digital Likeness Joint Venture

fuboTV (OTCQB:FBNK), FaceBank Group, Floyd Mayweather and ONE Entertainment Group, LLC today announced a ground-breaking joint venture to create and manage the world-renowned retired professional boxing champion and promoter’s digital likeness, “Virtual Mayweather.” The partnership […]

Newsmakers

CytoDyn (OTC: CYDY) Collaborating with U.K.’s Department of Health to ProvideEmergency Access to Leronlimab for Severe and Critically Ill COVID-19 Patients

April 7, 2020 admin Comments Off on CytoDyn (OTC: CYDY) Collaborating with U.K.’s Department of Health to ProvideEmergency Access to Leronlimab for Severe and Critically Ill COVID-19 Patients

CEO Nader Pourhassan will appear on FOX Business Network on April 7 at 11:00 am PT to provide an update on the Company’s two COVID-19 clinical trials and 15 patients on EIND VANCOUVER, Washington, Apr […]

Healthcare

CytoDyn (OTC: CYDY) First Two Patients Enrolled in Randomized Phase 2, COVID-19 Trial with Leronlimab; Five More Severely Ill COVID-19 Patients Treated Under Emergency IND and Two Patients Have Already Extubated

April 6, 2020 admin Comments Off on CytoDyn (OTC: CYDY) First Two Patients Enrolled in Randomized Phase 2, COVID-19 Trial with Leronlimab; Five More Severely Ill COVID-19 Patients Treated Under Emergency IND and Two Patients Have Already Extubated

Fifteen (15) severely ill COVID-19 patients have been treated under an EIND; 7-day results from the first four patients are available and are very promising; 7-day results for the first 10 patients will be available […]

Newsmakers

FaceBank Group (OTC: FBNK) and fuboTV Announce Completion of Merger – Combined Company to Be Named fuboTV, Inc.

April 2, 2020 admin Comments Off on FaceBank Group (OTC: FBNK) and fuboTV Announce Completion of Merger – Combined Company to Be Named fuboTV, Inc.

NEW YORK—-fuboTV, Inc., a leading live TV streaming platform, and FaceBank Group, Inc. (OTCQB: FBNK), a leading celebrity and sports focused virtual entertainment company, announced today the closing of their previously announced merger agreement. This […]

Healthcare

CytoDyn (OTC: CYDY) Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

March 31, 2020 admin Comments Off on CytoDyn (OTC: CYDY) Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

VANCOUVER, Washington, Mar 31, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]

Healthcare

FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

March 31, 2020 admin Comments Off on FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

VANCOUVER, Washington, March 31, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the […]

Healthcare

(OTC: CYDY) Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients

March 30, 2020 admin Comments Off on (OTC: CYDY) Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients

VANCOUVER, Washington, Mar 30, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that an […]

Healthcare

CytoDyn Files FDA-Suggested Modifications to IND and Protocol for Phase 2 Clinical Trial for COVID-19 Patients with Mild to Moderate Indications and a Second Randomized Protocol for All COVID-19 Patients in Severe Condition Will be Filed Next Week per FDA Recommendation

March 27, 2020 admin Comments Off on CytoDyn Files FDA-Suggested Modifications to IND and Protocol for Phase 2 Clinical Trial for COVID-19 Patients with Mild to Moderate Indications and a Second Randomized Protocol for All COVID-19 Patients in Severe Condition Will be Filed Next Week per FDA Recommendation

VANCOUVER, Washington, March 27, 2020  — CytoDyn Inc. (CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that, at the […]

Healthcare

(OTC: CYDY) Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with Reduced Pulmonary Inflammation

March 27, 2020 admin Comments Off on (OTC: CYDY) Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with Reduced Pulmonary Inflammation

IncellDx’s evaluation of test results from the first four patients suggests immunological benefit within three days following treatment with leronlimab on all four patients and lower level of cytokine storm, especially IL-6 and TNF-α, which […]

Newsmakers

NexTech AR (OTC: NEXCF) Reports $6 million in Revenues for its Audited Period Ended December 31st 2019

March 27, 2020 admin Comments Off on NexTech AR (OTC: NEXCF) Reports $6 million in Revenues for its Audited Period Ended December 31st 2019

Major Growth in AR Trends Seen Accelerating in 2020 NEW YORK and TORONTO, March 27, 2020 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for e-commerce and AR learning applications, reports that it […]

Newsmakers

FaceBank Group (OTC: FBNK) and fuboTV Announce Definitive Merger Agreement – Combined Company to Be Named fuboTV, Inc.

March 23, 2020 admin Comments Off on FaceBank Group (OTC: FBNK) and fuboTV Announce Definitive Merger Agreement – Combined Company to Be Named fuboTV, Inc.

– Proposed merger creates leading digital entertainment company offering cord-cutters a premium viewing experience across a global distribution network – Combined company to be led by David Gandler, CEO of fuboTV FaceBank Group, Inc. (otcqb:FBNK), […]

Healthcare

Two Additional Coronavirus Patients Treated at Leading New York Hospital with CytoDyn’s (OTC: CYDY) Leronlimab, Bringing the Total to Four Patients

March 23, 2020 admin Comments Off on Two Additional Coronavirus Patients Treated at Leading New York Hospital with CytoDyn’s (OTC: CYDY) Leronlimab, Bringing the Total to Four Patients

VANCOUVER, Washington, Mar 23, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the […]